Kim, Albert H.
Washington University in St. Louis
9 papers on CoChatORCID 0000-0002-1751-8493
Most cited papers
- Verified
Bioresorbable silicon electronic sensors for the brain
Kang, S.-K., Murphy, R. K. J., Hwang, S.-W., Lee, S. M., Harburg, D. V., Krueger, N. A., Shin, J., Gamble, P., Cheng, H., Yu, S., et al. (2016) · Nature
Neuroscience and Neural EngineeringWireless Body Area Networks
Cited by 998
- Verified
Proteogenomic and metabolomic characterization of human glioblastoma
Wang, L.-B., Karpova, A., Gritsenko, M. A., Kyle, J. E., Cao, S., Li, Y., Rykunov, D., Colaprico, A., Rothstein, J. H., Hong, R., et al. (2021) · Cancer Cell
Glioma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 661
- Verified
MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders
Kim, A. H., Reimers, M., Maher, B., Williamson, V., McMichael, O., McClay, J. L., van den Oord, E. J. C. G., Riley, B. P., Kendler, K. S., & Vladimirov, V. I. (2010) · Schizophrenia Research
Schizophrenia research and treatmentMicroRNA in disease regulation
Cited by 298
- Verified
TREM2 inhibition triggers antitumor cell activity of myeloid cells in glioblastoma
Sun, R., Han, R., McCornack, C., Khan, S., Tabor, G. T., Chen, Y., Hou, J., Jiang, H., Schoch, K. M., Mao, D. D., et al. (2023) · Science Advances
Glioma Diagnosis and TreatmentImmune cells in cancer
Cited by 119
- Verified
A phase I study to repurpose disulfiram in combination with temozolomide to treat newly diagnosed glioblastoma after chemoradiotherapy
Huang, J., Campian, J. L., Gujar, A. D., Tran, D. D., Lockhart, A. C., DeWees, T. A., Tsien, C. I., & Kim, A. H. (2016) · Journal of Neuro-Oncology
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 79
- Verified
Glioblastoma-Infiltrating CD8 + T Cells Are Predominantly a Clonally Expanded GZMK + Effector Population
Wang, A. Z., Mashimo, B. L., Schaettler, M. O., Sherpa, N. D., Leavitt, L. A., Livingstone, A. J., Khan, S. M., Li, M., Anzaldua-Campos, M. I., Bradley, J. D., et al. (2024) · Cancer Discovery
Cancer Immunotherapy and BiomarkersGlioma Diagnosis and Treatment
Cited by 73
- Verified
Final results of a phase I dose-escalation, dose-expansion study of adding disulfiram with or without copper to adjuvant temozolomide for newly diagnosed glioblastoma
Huang, J., Campian, J. L., Gujar, A. D., Tsien, C., Ansstas, G., Tran, D. D., DeWees, T. A., Lockhart, A. C., & Kim, A. H. (2018) · Journal of Neuro-Oncology
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 52
- Verified
Tumor-informed deep sequencing of ctDNA detects minimal residual disease and predicts relapse in osteosarcoma
Fu, Y., Xu, Y., Liu, W., Zhang, J., Wang, F., Jian, Q., Huang, G., Zou, C., Xie, X., Kim, A. H., et al. (2024) · eClinicalMedicine
Sarcoma Diagnosis and TreatmentCancer Genomics and Diagnostics
Cited by 37
- Verified
A Phase 1/2 Study of Disulfiram and Copper With Concurrent Radiation Therapy and Temozolomide for Patients With Newly Diagnosed Glioblastoma
Huang, J., Campian, J. L., DeWees, T. A., Skrott, Z., Mistrik, M., Johanns, T. M., Ansstas, G., Butt, O., Leuthardt, E., Dunn, G. P., et al. (2024) · International Journal of Radiation Oncology*Biology*Physics
Glioma Diagnosis and TreatmentPARP inhibition in cancer therapy
Cited by 34
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free